Papular Acrodermatitis

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 105 Experts worldwide ranked by ideXlab platform

R Gianotti - One of the best experts on this subject based on the ideXlab platform.

K. Rajender Reddy - One of the best experts on this subject based on the ideXlab platform.

  • Extrahepatic manifestations of chronic viral hepatitis
    Current Gastroenterology Reports, 2001
    Co-Authors: Nikolaos T. Pyrsopoulos, K. Rajender Reddy
    Abstract:

    Hepatitis B (HBV) and C (HCV) viruses are well-recognized causes for chronic hepatitis, cirrhosis, and even for hepatocellular carcinoma. Apart from liver disease, these viral infections are known to be associated with a spectrum of extrahepatic manifestations. The prevalence of clinically significant extrahepatic manifestations is relatively low, but it can be associated with significant morbidity and even mortality. An awareness and recognition of these manifestations is of paramount importance in facilitating early diagnosis and in offering treatment. However, treatments are not necessarily effective, and patients may continue with disabling extrahepatic manifestations. Hepatitis B virus has been well recognized as causing a variety of manifestations that include skin rash, arthritis, arthralgia, glomerulonephritis, polyarteritis nodosa, and Papular Acrodermatitis. More recently, infection with hepatitis C virus has elicited considerable interest for its role in a spectrum of extrahepatic manifestations. Among the best-reported are cryoglobulinemia, glomerulonephritis, high titer of autoantibodies, idiopathic thrombocytopenic purpura, lichen planus, Mooren’s corneal ulcer, Sjögren’s syndrome, porphyria cutanea tarda, and necrotizing cutaneous vasculitis. The precise pathogenesis of these extrahepatic complications has not been determined, although the majority represent the clinical expression of autoimmune phenomena.

Urbano Baldari - One of the best experts on this subject based on the ideXlab platform.

  • Skin disorders and Epstein Barr virus primary infection: results of a 31 month survey
    Journal of The European Academy of Dermatology and Venereology, 1995
    Co-Authors: Urbano Baldari, Claudio Cancellieri, Barbara Celli, Rossella Zanelli, Antonio Ascari Raccagni
    Abstract:

    Objectives To investigate skin disorders related to Epstein Barr Virus (EBV) seroconversion and review the literature on this topic. Patients and methods 77 patients admitted to three Departments (Dermatology, Infectious Diseases, Pediatrics) presented clinical and laboratory (Enzyme Linked Immunosorbent Assay) findings of EBV primary infection. 5477 (70.1%), ranging in age from 9 months to 41 years and suffering from various skin disorders, were selected. Results 854 presented Infantile Papular Acrodermatitis (Gianotti-Crosti syndrome); 4254 exanthema, 254 acute urticaria, 154 erythema multiforme, 154 erythema nodosum. Conclusion After reviewing the available literature on the subject and in the light of these findings, it is possible to assert that EBV-primary infection is not infrequently associated with skin symptoms. Clinicians may sometimes understimate the problem, and it would be useful to include EBV serology among the tests for the diagnosis of reactive cutaneous diseases occurring in subjects under 30 years old.

  • an epidemic of infantile Papular Acrodermatitis gianotti crosti syndrome due to epstein barr virus
    Dermatology, 1994
    Co-Authors: Urbano Baldari, A Monti, M G Righini
    Abstract:

    Five out of twelve 13- to 15-month-old children, attending the same class of a creche in Forli (Italy), presented infantile Papular Acrodermatitis (Gianotti-Crosti syndrome), associated with lymphocyt

Federico Gianotti - One of the best experts on this subject based on the ideXlab platform.

M G Righini - One of the best experts on this subject based on the ideXlab platform.